✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
圣和化工
首页 › 产品目录 › 阿瓦普替尼

阿瓦普替尼

CAS 1703793-34-3C26H27FN10MW 498.6

阿瓦普替尼,CAS 登记号 1703793-34-3,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于医药中间体及原料药。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号1703793-34-3
分子式C26H27FN10
分子量498.6
LogP1.9
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域医药中间体及原料药
类别医药中间体及原料药

用途与场景

医药中间体及原料药

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 阿瓦普替尼 的 CAS 号?

本页已列出 阿瓦普替尼 的 CAS 号:1703793-34-3,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

阿瓦普替尼 一般用在什么产品里?

主要涉及医药中间体及原料药。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

Avapritinib · CAS 1703793-34-3 · C26H27FN10. UNII 513P80B4YJ.

Identification

CAS Registry Number1703793-34-3
PubChem CID118023034
Molecular formulaC26H27FN10
IUPAC name(1S)-1-(4-fluorophenyl)-1-[2-[4-[6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl]pyrimidin-5-yl]ethanamine
UNII (FDA)513P80B4YJ

Computed Descriptors

Molecular Weight498.6
XLogP31.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count9
Rotatable Bond Count5
Exact Mass498.24041907
Monoisotopic Mass498.24041907
Topological Polar Surface Area106
Heavy Atom Count37
Formal Charge0

Physical description & handling notes

  • Avapritinib is a selective kinase inhibitor that negatively modulates the action of cell transporters to resensitize them to other chemotherapies. It has a long duration of action as it is given once daily. Patients should be counselled regarding the risk of intracranial hemorrhage, CNS effects, and embryo-fetal toxicity.

Documented Uses

  • Avapritinib is a tyrosine kinase receptor inhibitor that targets mutant forms of several genes (KIT, PDGFRA) involved in gastrointestinal stromal tumors which are often found in refractory cases. Serum aminotransferase elevations arise in a small proportion of patients treated with the highest doses of avapritinib, but episodes of clinically apparent liver injury have not been reported with its use.
  • Breast Feeding; Lactation; Milk, Human; Antineoplastic Agents; Enzyme Inhibitors; Protein Kinase Inhibitors; Signal Transduction Inhibitors; Tyrosine Kinase Inhibitors
  • Avapritinib is approved to treat adults with:
  • • Gastrointestinal stromal tumor (GIST) that cannot be removed by surgery or has metastasized (spread to other parts of the body) and has certain mutations in the PDGFRA gene.
  • • Systemic mastocytosis that is advanced, including the following types:
  • • Aggressive systemic mastocytosis.

Synonyms

Avapritinib; 1703793-34-3; BLU-285; Ayvakit; 513P80B4YJ; C-366; 70C366; DTXSID301027935; X720776; X-720776; avapritinibum; RefChem:56916; DTXCID501513502; CS3007; PDGFR alpha/KIT Mutant-specific Inhibitor BLU-285; MFCD31544325

Frequently Asked Questions

What are the CAS number and molecular formula of Avapritinib?

CAS 1703793-34-3; molecular formula C26H27FN10; molecular weight — g/mol.

What other names is Avapritinib known by?

Avapritinib, 1703793-34-3, BLU-285, Ayvakit, 513P80B4YJ, C-366.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 阿瓦普替尼 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1